Partex.AI Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
250
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Partex.AI General Information
Description
Developer of advanced artificial intelligence and blockchain technology platform designed to support all stages of drug development from pipeline to market. The company's platform identifies and extracts structured and unstructured life science data by scanning the World Wide Web and merges it with enterprise and third-party data in an ongoing, real-time process, enabling life sciences organizations to generate actionable information across pre-clinical, clinical, regulatory, and commercial stages of drug development using data analytics.
Contact Information
Website
www.partex.aiCorporate Office
- Frankfurter Strasse 27
- 65760 Eschborn
- Germany
Corporate Office
- Frankfurter Strasse 27
- 65760 Eschborn
- Germany
Partex.AI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 17-Jul-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 08-Mar-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 25-Apr-2019 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 23-May-2018 | Completed | Generating Revenue | |||
| 2. Seed Round | 22-Dec-2016 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Partex.AI Comparisons
Industry
Financing
Details
Partex.AI Competitors (15)
One of Partex.AI’s 15 competitors is Exscientia, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| Pelago Bioscience | Private Equity-Backed | Stockholm, Sweden | ||||
| Lynx Biosciences | Venture Capital-Backed | San Diego, CA | ||||
| PredxBio | Venture Capital-Backed | Pittsburgh, PA | ||||
| BenevolentAI | Formerly PE-Backed | Luxembourg, Luxembourg |
Partex.AI Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Partex.AI Patents
Partex.AI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250077212-A1 | System and method for updating application data on graphical processing unit | Inactive | 31-Aug-2023 | ||
| US-20250046392-A1 | System and method for aiding drug development | Pending | 31-Jul-2023 | ||
| US-20240403333-A1 | System and method for electronic processing of data items for enhanced search | Inactive | 31-May-2023 | ||
| US-20240362414-A1 | Method and system for electronic decomposition of data string into structurally meaningful parts | Inactive | 28-Apr-2023 | ||
| US-20240363196-A1 | System and method for identifying molecular pathways perturbed under influence of drug or disease | Pending | 27-Apr-2023 | G16B25/10 |
Partex.AI Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Partex.AI Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Panacea VC | Venture Capital | Minority | ||
| Block.one | Growth/Expansion | Minority | ||
| C3 Venture Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Heliad | Venture Capital | Minority |
Partex.AI FAQs
-
When was Partex.AI founded?
Partex.AI was founded in 2011.
-
Where is Partex.AI headquartered?
Partex.AI is headquartered in Eschborn, Germany.
-
What is the size of Partex.AI?
Partex.AI has 250 total employees.
-
What industry is Partex.AI in?
Partex.AI’s primary industry is Biotechnology.
-
Is Partex.AI a private or public company?
Partex.AI is a Private company.
-
What is Partex.AI’s current revenue?
The current revenue for Partex.AI is .
-
How much funding has Partex.AI raised over time?
Partex.AI has raised $68.3M.
-
Who are Partex.AI’s investors?
Panacea VC, Block.one, C3 Venture Capital, , and Heliad are 5 of 6 investors who have invested in Partex.AI.
-
Who are Partex.AI’s competitors?
Exscientia, Pelago Bioscience, Lynx Biosciences, PredxBio, and BenevolentAI are some of the 15 competitors of Partex.AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
